Skip to ContentGo to accessibility pageKeyboard shortcuts menu
OpenStax Logo
Pharmacology for Nurses

39.3 Otic Antihistamines, Decongestants, and Cerumenolytics

Pharmacology for Nurses39.3 Otic Antihistamines, Decongestants, and Cerumenolytics

Learning Outcomes

By the end of this section, you should be able to:

  • 39.3.1 Identify the characteristics of antihistamines, decongestants, and cerumenolytic drugs used to treat ear disorders.
  • 39.3.2 Explain the indications, actions, adverse reactions, and interactions of antihistamines, decongestants, and cerumenolytic drugs used to treat ear disorders.
  • 39.3.3 Describe nursing implications of antihistamines, decongestants, and cerumenolytic drugs used to treat ear disorders.
  • 39.3.4 Explain the client education related to antihistamines, decongestants, and cerumenolytic drugs used to treat ear disorders.

Antihistamines

Antihistamines decrease congestion of mucous membranes, which might decrease corresponding obstruction of tubes within the ear. Antihistamines are used primarily to treat allergies and manage symptoms related to upper respiratory infections. Selected first-generation antihistamines are included here. Please refer to Upper Respiratory Disorder Drugs for a more detailed review of antihistamine medications.

Table 39.6 lists common antihistamines for ear disorders and typical routes and dosing for adult and pediatric clients.

Drug Routes and Dosage Ranges
Chlorpheniramine maleate
(Chlor-Trimeton)
Adults and children ≥12 years: 4 mg tablet orally every 4–6 hours as needed. Maximum dose: 6 tablets/day.
Children 6–12 years: ½ of a 4 mg tablet every 4–6 hours. Maximum dose: 3 tablets/day.
Children <6 years: Do not use.
Cetirizine hydrochloride
(Zyrtec)
Adults and children >6 years: 10 mg once daily; do not take more than 10 mg in 24 hours. A 5 mg product may be appropriate for less severe symptoms.
Diphenhydramine
(Benadryl)
Adults and children >12 years: 25–50 mg orally every 4–6 hours as needed. Maximum of 6 doses in 24 hours.
Children 6–12 years: 25 mg orally every 6 hours as needed not to exceed 4 doses in 24 hours.
Children <6 years: Do not use.
Loratadine
(Claritin)
Adults and children >6 years: 10 mg once daily; do not take more than 10 mg in 24 hours.
Table 39.6 Drug Emphasis Table: Antihistamines (source: https://dailymed.nlm.nih.gov/dailymed/)

Adverse Effects and Contraindications

The use of antihistamines in clients with hypertension can further increase blood pressure. Clients at risk for cardiac dysrhythmia, such as a prolonged QT interval on an electrocardiogram, should communicate with their provider before taking a first-generation antihistamine like diphenhydramine due to potential proarrhythmic effects (Williamson, 2022). Since antihistamines have a drying effect, clients with glaucoma and urinary retention should avoid taking an antihistamine. Antihistamines exacerbate the sedating effects of tranquilizers and alcohol, which can lead to respiratory depression and injuries from falls. Due to antihistamines’ blocking effects on acetylcholine, they can also cause constipation.

Table 39.7 is a drug prototype table for first-generation antihistamines featuring diphenhydramine. It lists drug class, mechanism of action, adult and pediatric dosage, indications, therapeutic effects, drug and food interactions, adverse effects, and contraindications.

Drug Class
Antihistamine

Mechanism of Action
Stops chemicals in the immune system that trigger allergy-related symptoms
Drug Dosage
Adults and children >12 years: 25–50 mg orally every 4–6 hours as needed. Maximum of 6 doses in 24 hours.
Children 6–12 years: 25 mg orally every 6 hours as needed not to exceed 4 doses in 24 hours.
Children <6 years: Do not use.
Indications
For the treatment of symptoms associated with the common cold or allergic rhinitis including sneezing, rhinorrhea, itching of the nose or throat, and itchy, watery eyes

Therapeutic Effects
Temporary relief of rhinitis, sneezing, itchy eyes, nose, or throat due to upper respiratory inflammation
Drug Interactions
Sedatives and tranquilizers with sedative effects
Alcohol

Food Interactions
No significant interactions
Adverse Effects
Drowsiness
Dry mouth
Dizziness
Headache
Constipation
Contraindications
Hypertension
Cardiovascular arrhythmia
History of glaucoma
Urinary retention

Caution:
Operating a motor vehicle or machinery
Table 39.7 Drug Prototype Table: Diphenhydramine (source: https://dailymed.nlm.nih.gov/dailymed/)

Nursing Implications

The nurse should do the following for clients who are taking antihistamines:

  • Monitor the client for potential side effects including drowsiness or oversedation.
  • Educate the client to refrain from driving or operating machinery while taking these medications because they can cause drowsiness and impair cognitive function.
  • Educate the client to guard against potential constipation by increasing fiber and fluid intake.
  • Provide client teaching regarding the drug and when to call the health care provider. See below for client teaching guidelines.

Client Teaching Guidelines

The client taking an antihistamine should:

  • Be aware that antihistamines can cause drowsiness.
  • Keep fluids or hard candy on hand to manage symptoms of dry mouth.
  • Maintain adequate fiber and fluid intake to reduce likelihood of experiencing constipation.

The client taking an antihistamine should not:

  • Drive or operate machinery when feeling drowsy.

Decongestants

Decongestants are medications that shrink swollen blood vessels and tissues in the nose to reduce nasal congestion, which can facilitate drainage to relieve ear congestion. They can be used to manage symptoms of an upper respiratory illness or prophylactically when flying to decrease discomfort associated with changes in air pressure. These medications should be used with caution in clients with a history of heart disease, thyroid disorder, diabetes, or hypertension. Alternatives include using saline nasal spray, room humidification, or being in a room with a hot shower running that creates a steamy environment. (For more detailed information on decongestants, please see Upper Respiratory Disorder Drugs.)

Adverse Effects and Contraindications

Decongestants should be avoided in clients who have a history of hypertension or heart disease because these medications can raise blood pressure and stimulate the heart. They can increase intraocular pressure in clients who have glaucoma; particularly among clients with benign prostatic hypertrophy, decongestants can inhibit the ability to void.

Table 39.8 is a drug prototype table for decongestants featuring pseudoephedrine (Sudafed). It lists drug class, mechanism of action, adult and pediatric dosage, indications, therapeutic effects, drug and food interactions, adverse effects, and contraindications.

Drug Class
Nasal decongestant

Mechanism of Action
Indirectly stimulates alpha-adrenergic receptors, causing vasoconstriction
Drug Dosage
Regular-release tablets or liquid-filled capsules:
Adults and children ≥12 years: 60 mg orally every 4–6 hours; maximum dose: 240 mg daily.
Children 6–11 years: 30 mg orally every 4–6 hours; maximum dose: 120 mg daily.
12-hour extended-release tablets:
Adults: 120 mg orally (1 tablet) every 12 hours; maximum dose: 240 mg daily.
24-hour extended-release tablets:
Adults: 240 mg orally every 24 hours; maximum dose: 240 mg daily.
Oral solution containing 15 mg or 30 mg pseudoephedrine per 5 mL:
Adults: 60 mg orally every 4–6 hours; maximum dose: 240 mg daily.
Indications
For temporary relief of sinus congestion and pressure
For temporary relief of nasal congestion due to a cold or other upper respiratory allergies

Therapeutic Effects
Eases discomfort and allergy symptoms
Drug Interactions
Monoamine oxidase inhibitors (MAOIs)

Food Interactions
No significant interactions
Adverse Effects
Insomnia
Anxiety
Elevated blood pressure
Elevated glucose
Increased intraocular pressure
Worsening glaucoma
Contraindications
Heart disease
Hypertension
Thyroid disease
Diabetes
Urinary retention due to enlarged prostate gland
Table 39.8 Drug Prototype Table: Pseudoephedrine (sources: https://dailymed.nlm.nih.gov/dailymed/; Glowacka & Wiela-Hojenska, 2021)

Nursing Implications

The nurse should do the following for clients who are taking decongestants:

  • Monitor the client’s blood pressure, especially if they have a history of hypertension, and report elevated readings to the provider.
  • Monitor the client’s blood glucose levels if the client has diabetes and report elevated readings to the provider.
  • Be aware that decongestants can raise intraocular pressure. This can be especially concerning for clients with glaucoma. Assess the client for any visual changes, eye pain or irritation, or headache. Report any findings to the provider.
  • Provide client teaching regarding the drug and when to call the health care provider. See below for client teaching guidelines.

Client Teaching Guidelines

The client taking a decongestant should:

  • Talk to their health care provider before starting a decongestant, especially if underlying health conditions exist.
  • Check their blood pressure while taking decongestants if they have prehypertension/hypertension.
  • Monitor their blood glucose levels while taking decongestants if they have prediabetes/diabetes.
  • If they have glaucoma, check with their ophthalmologist about decongestant use and report any visual changes, eye pain, or headache.
  • Take decongestants for the shortest amount of time possible and do not take multiple decongestants from different decongestant classes.
  • Clients taking monoamine oxidase inhibitors (MAOI) and decongestants can experience hypertensive crisis (Edinoff et al., 2022).

Otic Cerumenolytics

Typically, the body naturally expels earwax; however, sometimes a buildup occurs requiring the administration of medication to facilitate its removal. A commonly prescribed cerumenolytic is carbamide peroxide (Debrox). The drops work by releasing oxygen to soften and encourage spontaneous extrusion of cerumen. They also have a weak antibacterial effect.

Table 39.9 is a drug prototype table for otic cerumenolytics featuring carbamide peroxide. It lists drug class, mechanism of action, adult and pediatric dosage, indications, therapeutic effects, drug and food interactions, adverse effects, and contraindications.

Drug Class
Otic cerumenolytic

Mechanism of Action
Contains peroxide, which creates foaming that softens and breaks apart the wax
Drug Dosage
Adults and children ≥12 years: 5–10 drops of the 6.5% solution in ear twice daily for up to 4 days.
Indications
To soften and encourage spontaneous extrusion of cerumen

Therapeutic Effects
Facilitates ear wax removal
Drug Interactions
No significant interactions

Food Interactions
No significant interactions
Adverse Effects
Ear discomfort
Transient loss of hearing
Dizziness
Local irritation
Contraindications
Ear infection
Ear pain
Ear rash
Recent ear surgery
Eardrum dysfunction
Table 39.9 Drug Prototype Table: Carbamide Peroxide (source: https://dailymed.nlm.nih.gov/dailymed/)

Nursing Implications

The nurse should do the following for clients who are taking an otic cerumenolytic:

  • Educate clients about the benefits of ear wax and how the ear is a self-cleaning organ.
  • Examine the client’s ears before treatment for any evidence of drainage or other symptoms that would prevent safe administration. Consult with the provider if concerning finding are present.
  • Examine the client’s ears after treatment using an otoscope to determine effectiveness of treatment. If no results are obtained, notify the provider for further evaluation.
  • After administering the medication, any remaining wax can be removed by gentle irrigation with warm water.
  • Provide client teaching regarding the drug and when to call the health care provider. See below for client teaching guidelines.

Client Teaching Guidelines

The client taking an otic cerumenolytic should:

  • Use in consultation with their provider.
  • Pull the pinna in an upward fashion to instill drops.
  • Remain in a lying position for 5 minutes after instillation.
  • Report ear discomfort, dizziness, or local discomfort.

The client taking an otic cerumenolytic should not:

  • Instill cerumenolytic drops after recent ear surgery or if there is eardrum dysfunction.
Citation/Attribution

This book may not be used in the training of large language models or otherwise be ingested into large language models or generative AI offerings without OpenStax's permission.

Want to cite, share, or modify this book? This book uses the Creative Commons Attribution License and you must attribute OpenStax.

Attribution information
  • If you are redistributing all or part of this book in a print format, then you must include on every physical page the following attribution:
    Access for free at https://openstax.org/books/pharmacology/pages/1-introduction
  • If you are redistributing all or part of this book in a digital format, then you must include on every digital page view the following attribution:
    Access for free at https://openstax.org/books/pharmacology/pages/1-introduction
Citation information

© May 15, 2024 OpenStax. Textbook content produced by OpenStax is licensed under a Creative Commons Attribution License . The OpenStax name, OpenStax logo, OpenStax book covers, OpenStax CNX name, and OpenStax CNX logo are not subject to the Creative Commons license and may not be reproduced without the prior and express written consent of Rice University.